ActiveNANCT05965245

Suubi-Mhealth: A Mobile Health Intervention to Address Depression and Improve ART Adherence Among Youth Living With HIV (YLHIV) in Uganda

Sponsor: Washington University School of Medicine

Trial Details

Condition	Depression, HIV Infection
Intervention	Suubi-Mhealth
Phase	NA
Status	Active
Participants	278
Est. Completion	31 Aug 2027
Last Updated	12 May 2026

Primary Outcome

Patient Health Questionnaire (PHQ-9) Health Questionnaire (PHQ-9)

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Ages 14-17 years * HIV positive and aware of their status i.e., disclosed to * Prescribed antiretroviral therapy * Living within a family, including with extended family members (not in institutions) * Health care providers who work with youth at participating clinics who agree to participate in the study. Exclusion Criteria: * A significant cognitive impairment that interferes with the participant's understanding of the informed consent process, or inability/unwillingness to commit to completing the study

Trial Sites

Countries

United StatesUganda

View Registry Entry

Related Analysis

Suubi-Mhealth Trial: Mobile CBT Intervention for Depression and ART Adherence in HIV-Positive Youth — Addressing Global Health Disparities

The Suubi-Mhealth trial is testing a mobile CBT intervention for HIV-positive youth with depression in Uganda, targeting improved mental health outcomes and antiretroviral therapy adherence. This innovative approach addresses critical gaps in mental health care for vulnerable adolescent populations in resource-limited settings.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service